Benzinga - Tue, 24 Mar 2020 11:35:03 -0400
WuXi Biologics ("WuXi") is a contract development and manufacturing organization, or "CDMO", for biologic drugs. It was founded in 2010 as part of WuXi AppTec and listed on the Hong Kong Stock Exchange in 2017. WuXi provides comprehensive services from conception to commercialization, including drug discovery, clinical and commercial manufacturing, and various support services such as process validation, viral clearance studies, product and cell line characterization, stability studies, and others. It does not conduct clinical trials. WuXi reported CNY 4 billion of revenue in 2019 and a three-year CAGR of 59%. Revenue by geography was 54% from North America, 35% from China, and 8% from Europe. About 45% of its projects are pre-IND (that is prior to clinical testing) and 65% were post-IND.

Related Companies

TickerCompanyChg %Mkt Cap
WXXWYWuXi Biologics (Cayman)0.09%49B

WuXi Biologics (Cayman) Company Questions & Answers

Q

How do I buy WuXi Biologics (Cayman) (WXXWY) stock?

A

You can purchase shares of WuXi Biologics (Cayman) (OTC: WXXWY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are WuXi Biologics (Cayman)'s (WXXWY) main competitors?

A

There are no as such competitors for WuXi Biologics (Cayman).

Q

What is the target price for WuXi Biologics (Cayman)?

A

There is no analysis for WuXi Biologics (Cayman)

Q

How much is WuXi Biologics (Cayman) (WXXWY) stock ?

A

The stock price for WuXi Biologics (Cayman) (OTC: WXXWY) is $23.28 last updated Fri Mar 05 2021 20:59:30 GMT+0000 (Coordinated Universal Time).

Q

When is the next WuXi Biologics (Cayman) (WXXWY) dividend?

A

There are no upcoming dividends for WuXi Biologics (Cayman).

Q

When is WuXi Biologics (Cayman) (OTC:WXXWY) reporting earnings?

A

There are no earnings for WuXi Biologics (Cayman)

Q

When is the upcoming split for WXXWY?

A

There is no upcoming split for WuXi Biologics (Cayman).